4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Jasper Therapeutics, Inc. (JSPR) operates in the Biotechnology industry and is headquartered in Redwood City, United States with about 22 employees. Its market capitalization is roughly $16 million. In the fiscal year ended 2025-12-31, JSPR reported $0M in revenue and ($76M) in net income.
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($84M) | ($76M) | ($69M) | ($51M) | — |
| Net Income | ($76M) | ($71M) | ($64M) | ($38M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($11M) | ($16M) | ($19M) | ($27M) | ($22M) | — |
| Net Income | ($1M) | ($9M) | ($19M) | ($27M) | ($21M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $36M | $80M | $95M | $48M | — |
| Total Liabilities | $32M | $18M | $16M | $12M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive JSPR viewer.
About TickerBase · Data methodology & sources